Clinical Trial Update: Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of roflumilast in patients with asthma has completed; results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED